Chest
DIAGNOSIS AND MANAGEMENT OF LUNG CANCER: ACCP GUIDELINES (2ND EDITION)Evidence for the Treatment of Patients With Pulmonary Nodules: When Is It Lung Cancer?: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Section snippets
Materials and Methods
The review methods were defined prospectively in a written protocol. The SPN Guideline Subcommittee, who authored the accompanying guideline, was consulted. Primary outcomes included prevalence of SPNs, stratified by smoking status, age, and other risk factors; prevalence of malignancy associated with specific nodule characteristics; histologic type and growth rates associated with specific nodule characteristics; diagnostic accuracy (sensitivity, specificity) of tests to determine whether a
What Is the Prevalence of SPNs?
From the literature review, eight large studies4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18 of lung cancer screening were identified (Table 1). It is important to note that nodules that are detected in screening studies differ in important ways from nodules that are detected in routine clinical practice. In screening studies, the nodules tend to be smaller, the prevalence of malignant nodules is much lower, and the tumor volume doubling times (VDTs) of malignant nodules are generally
What Is the Prevalence of Malignancy in Nodules With Varying Characteristics?
We identified three nodule characteristics for analysis: size, morphology, and type of opacity (Table 234). Seven studies5, 9, 16, 19, 20, 21, 22 that assessed nodule size found a proportional increase in the risk for malignancy as the diameter of the nodule increased (Table 2). With the exception of one small retrospective study20 in which two of two nodules < 5 mm in diameter were malignant, the prevalence of malignancy in nodules that measured < 5 mm was exceedingly low (range, 0 to 1%). The
What Is the Histologic Type and Natural History (Growth Rate) of Small Pulmonary Nodules With Varying Characteristics?
Nine studies9, 10, 27, 28, 29, 30, 31, 32, 33 analyzed the histology of pulmonary nodules with purely or primarily ground-glass attenuation on HRCT (Table 5). Bronchioloalveolar carcinoma (BAC) was the most common histologic subtype in such nodules (range, 70 to 100%).
Hasegawa et al10 reported the VDT for malignant SPNs on the basis of their morphologic characteristics: 813 ± 375 days for pure ground-glass opacities, 457 ± 260 days for mixed or partial ground-glass opacities, and 149 ± 125 days
What Are the Performance Characteristics of Tests for SPN Diagnosis?
An abundant body of evidence exists for the performance of positron emission tomography (PET) in the evaluation of SPN. Except for one study, the sensitivity of PET for identifying malignancy was consistently high (80 to 100%; Table 6).34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50 In contrast, the specificity of PET was lower and highly variable (40 to 100%). The point on the summary receiver operating characteristic curve that corresponded to the median specificity
What Is the Prevalence of SPNs?
The prevalence of SPNs (8 to 51%) and the prevalence of malignancy in patients with SPNs (1.1 to 12%) varied significantly across studies. This variation stems from the inconsistency among studies in method, enrolled population, and reporting of results.
What Is the Prevalence of Malignancy in Nodules With Varying Characteristics (Size, Morphology, and Type of Opacity)?
The prevalence of malignancy in SPNs increased in proportion to size: 0 to 1% for nodules < 5 mm, 6 to 28% for nodules 5 to 10 mm, and 64 to 82% for nodules > 20 mm. Data from six studies9, 21, 22, 23, 24, 25 of patients with incidental or
Discussion
In patients with incidentally detected SPNs, treatment goals include prompt identification of malignant nodules to permit timely surgical resection and avoidance of surgery (when possible) in patients with benign nodules. Patients with SPNs and their clinicians confront challenging treatment decisions and must weigh the risks and benefits of various treatment strategies. Our report sought answers to key questions that are frequently posed when an SPN is encountered.
Our first question addressed
Conclusions
Our report sought evidence related to the prevalence of SPNs, the prevalence of malignancy in patients with SPNs, characteristics of SPNs associated with malignancy, and accuracy of tests that are used for SPN diagnosis. It is clear that further research is needed to address vital questions such as the prevalence of SPNs in the population at large, the characteristics that indicate malignancy, and the best management strategy. Essential steps toward more rigorous research must include the
REFERENCES (67)
- et al.
Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung Screening Study of the National Cancer Institute
Chest
(2004) - et al.
Lung cancer screening using low-dose spiral CT: results of baseline and 1-year follow-up studies
Chest
(2002) - et al.
Early Lung Cancer Action Project: overall design and findings from baseline screening
Lancet
(1999) - et al.
Video-assisted thoracoscopic surgery for small indeterminate pulmonary nodules: indications for preoperative marking
Chest
(1999) - et al.
A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions
Ann Thorac Surg
(2003) - et al.
Small lung tumors with the size of 1cm or less in diameter: clinical, radiological, and histopathological characteristics
Lung Cancer
(2004) - et al.
Lung cancer patients showing pure ground-glass opacity on computed tomography are good candidates for wedge resection
Lung Cancer
(2004) - et al.
Prospective study of thoracoscopic limited resection for ground-glass opacity selected by computed tomography
Ann Thorac Surg
(2003) - et al.
“Early” peripheral lung cancer: prognostic significance of ground glass opacity on thin-section computed tomographic scan
Ann Thorac Surg
(2002) - et al.
Results of wedge resection for focal bronchioloalveolar carcinoma showing pure ground-glass attenuation on computed tomography
Ann Thorac Surg
(2002)
Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules: potential role in evaluation and management
Chest
PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions: a comparative risk-benefit analysis
Chest
Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography
Ann Thorac Surg
Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan
Chest
Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions
Chest
FDG-PET imaging and the diagnosis of non-small cell lung cancer in a region of high histoplasmosis prevalence
Lung Cancer
The challenge of solitary pulmonary nodules: HRCT evaluation
Comput Med Imaging Graph
CT-guided fine-needle aspiration cytology of solitary pulmonary nodules: a prospective, randomized study of immediate cytologic evaluation
Chest
CT-guided transthoracic needle biopsy of small solitary pulmonary nodules
Clin Imaging
CT-guided transthoracic needle biopsy of pulmonary nodules smaller than 20 mm: results with an automated 20-gauge coaxial cutting needle
Clin Radiol
Usefulness of new automated cutting needle for tissue-core biopsy of lung nodules under CT fluoroscopic guidance
Chest
Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis
JAMA
Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules
Ann Intern Med
Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society
Radiology
Low dose spiral computed tomography for early diagnosis of lung cancer: results of baseline screening in 5,000 high-risk volunteers; ASCO Annual Meeting Proceedings Part I
J Clin Oncol
CT screening for lung cancer: suspiciousness of nodules according to size on baseline scans
Radiology
Malignant versus benign nodules at CT screening for lung cancer: comparison of thin-section CT findings
Radiology
Lung cancers missed at low-dose helical CT screening in a general population: comparison of clinical, histopathologic, and imaging findings
Radiology
Small solitary pulmonary nodules (≤1 cm) detected at population-based CT screening for lung cancer: reliable high-resolution CT features of benign lesions
AJR Am J Roentgenol
Growth rate of small lung cancers detected on mass CT screening
Br J Radiol
Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner
Br J Cancer
Lung cancer screening with CT: Mayo Clinic experience
Radiology
Screening for lung cancer with low-dose spiral computed tomography
Am J Respir Crit Care Med
Cited by (399)
18F-FDG PET/CT anatomic and metabolic guidance in CT-guided lung biopsies
2024, European Journal of RadiologyCT characteristics of solid pulmonary nodules of never smokers versus smokers: A population-based study
2022, European Journal of RadiologyCryobiopsy and dye marking guided by electromagnetic navigation bronchoscopy before resection of pulmonary nodule
2022, Respiratory Medicine and ResearchDecreasing Prevalence of Benign Etiology in Resected Lung Nodules Suspicious for Lung Cancer over the Last Decade
2022, Seminars in Thoracic and Cardiovascular SurgeryComparison of the safety and effectiveness of the four-hook needle and hook wire for the preoperative positioning of localization ground glass nodules
2024, Journal of Cardiothoracic Surgery
The authors have reported to the ACCP that no significant conflicts of interest exist with any companies/organizations whose products or services may be discussed in this article.
Reproduction of this article is prohibited without written permission from the American College of Chest Physicians (www.chestjournal.org/misc/reprints.shtml).